Related references
Note: Only part of the references are listed.Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015)
Wen Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
An integrated molecular modeling approach for in silico design of new tetracyclic derivatives as ALK inhibitors
Saikiran Reddy Peddi et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2016)
Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity
Francesca Curreli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structure-Based Design, Synthesis and Validation of CD4-Mimetic Small Molecule Inhibitors of HIV-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist
Joel R. Courter et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
Alon Herschhorn et al.
NATURE CHEMICAL BIOLOGY (2014)
Molecular docking guided structure based design of symmetrical N,N′-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors
Sree Kanth Sivan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Inhibitors of HIV-1 attachment. Part 8: The effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors
Kap-Sun Yeung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents
Kap-Sun Yeung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Inhibitors of HIV-1 attachment. Part 10. The discovery and structure-activity relationships of 4-azaindole cores
Tao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Inhibitors of HIV-1 attachment. Part 11: The discovery and structure-activity relationships associated with 4,6-diazaindole cores
John A. Bender et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors
Mahesh Kumar Teli et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)
John F. Kadow et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
CD4 mimics targeting the mechanism of HIV entry
Yuko Yamada et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1
Babafemi Taiwo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
3D QSAR of Aminophenyl Benzamide Derivatives as Histone Deacetylase Inhibitors
Mahipal et al.
MEDICINAL CHEMISTRY (2010)
Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns
Nicholas A. Meanwell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives
Tao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity
Nicholas A. Meanwell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions
Fabiana Caporuscio et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects
Tao Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Base-free monosulfonylation of amines using tosyl or mesyl chloride in water
Ahmed Kamal et al.
TETRAHEDRON LETTERS (2008)
The synthesis and crystal structures of new 2-aminomethylbenzimidazole Zinc(II) complexes exhibiting luminescence
Hong-Yan Wu et al.
TRANSITION METAL CHEMISTRY (2008)
Design and synthesis of human immunodeficiency virus entry inhibitors:: Sulfonamide as an isostere for the α-ketoamide group
Rong-Jian Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus
Hui Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Direct one-pot synthesis of β-hydroxysulfides from terminal olefins in a mixture of [bmim][BF4] and water in presence of molecular oxygen
Ahmed Kamal et al.
JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL (2007)
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Steven L. Dixon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
An efficient solid-phase synthesis of biologically important DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepine dimers (DSB-120) and their C2-fluorinated analogues
Ahmed Kamal et al.
TETRAHEDRON LETTERS (2006)
Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring
Paul D. Lyne et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Selective reduction of aromatic azides in solution/solid-phase and resin cleavage by employing BF3•OEt2/EtSH.: Preparation of DC-81
Ahmed Kamal et al.
TETRAHEDRON LETTERS (2006)
PHASE: A novel approach to pharmacophore modeling and 3D database searching
Steven L. Dixon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events
HT Ho et al.
JOURNAL OF VIROLOGY (2006)
Polyethylene glycol (PEG) as an efficient recyclable medium for the synthesis of β-amino sulfides
A Kamal et al.
TETRAHEDRON LETTERS (2006)
Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor
K Vermeire et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Chemoenzymatic synthesis of calcilytic agent NPS-2143 employing a lipase-mediated resolution protocol
A Kamal et al.
TETRAHEDRON-ASYMMETRY (2005)
A task-specific ionic liquid [bmim] SCN for the conversion of alkyl halides to alkyl thiocyanates at room temperature
A Kamal et al.
TETRAHEDRON LETTERS (2005)
Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins
ZH Si et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Chemoenzymatic synthesis of enantiomerically pure 1,2-diols employing immobilized lipase in the ionic liquid [bmim]PF6
A Kamal et al.
TETRAHEDRON LETTERS (2004)
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
PF Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Phosphodiesterase 5 inhibitors: Current status and potential applications
DP Rotella
NATURE REVIEWS DRUG DISCOVERY (2002)
New developments in anti-HIV chemotherapy
E De Clercq
CURRENT MEDICINAL CHEMISTRY (2001)
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
GA Kaminski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
Deprotection of 2-pyridyl sulfonyl group from pyridine-2-sulfonamides by magnesium in methanol
CS Pak et al.
SYNTHETIC COMMUNICATIONS (2001)
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates
PD Kwong et al.
STRUCTURE (2000)
Share Paper
